Plebanski M - Search Results

1

Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy.

Park A, Govindaraj C, Xiang SD, Halo J, Quinn M, Scalzo-Inguanti K, Plebanski M. Park A, et al. Among authors: plebanski m. Cancers (Basel). 2012 Jun 18;4(2):581-600. doi: 10.3390/cancers4020581. Cancers (Basel). 2012. PMID: 24213326 Free PMC article.

2

Vaccines that facilitate antigen entry into dendritic cells.

Gamvrellis A, Leong D, Hanley JC, Xiang SD, Mottram P, Plebanski M. Gamvrellis A, et al. Among authors: plebanski m. Immunol Cell Biol. 2004 Oct;82(5):506-16. doi: 10.1111/j.0818-9641.2004.01271.x. Immunol Cell Biol. 2004. PMID: 15479436 Review.

3

Pathogen recognition and development of particulate vaccines: does size matter?

Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Methods. 2006 Sep;40(1):1-9. doi: 10.1016/j.ymeth.2006.05.016. Methods. 2006. PMID: 16997708 Review.

4

Methods for nano-particle based vaccine formulation and evaluation of their immunogenicity.

Kalkanidis M, Pietersz GA, Xiang SD, Mottram PL, Crimeen-Irwin B, Ardipradja K, Plebanski M. Kalkanidis M, et al. Among authors: plebanski m. Methods. 2006 Sep;40(1):20-9. doi: 10.1016/j.ymeth.2006.05.018. Methods. 2006. PMID: 16997710

5

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.

Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, Vardaxis N, Plebanski M. Mottram PL, et al. Among authors: plebanski m. Mol Pharm. 2007 Jan-Feb;4(1):73-84. doi: 10.1021/mp060096p. Mol Pharm. 2007. PMID: 17274665

6

Investigation of a novel approach to scoring Giemsa-stained malaria-infected thin blood films.

Proudfoot O, Drew N, Scholzen A, Xiang S, Plebanski M. Proudfoot O, et al. Among authors: plebanski m. Malar J. 2008 Apr 21;7:62. doi: 10.1186/1475-2875-7-62. Malar J. 2008. PMID: 18426594 Free PMC article.

7

Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.

Greenwood DL, Dynon K, Kalkanidis M, Xiang S, Plebanski M, Scheerlinck JP. Greenwood DL, et al. Among authors: plebanski m. Vaccine. 2008 May 23;26(22):2706-13. doi: 10.1016/j.vaccine.2008.03.025. Epub 2008 Apr 3. Vaccine. 2008. PMID: 18448209

8

Promising particle-based vaccines in cancer therapy.

Xiang SD, Scalzo-Inguanti K, Minigo G, Park A, Hardy CL, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Expert Rev Vaccines. 2008 Sep;7(7):1103-19. doi: 10.1586/14760584.7.7.1103. Expert Rev Vaccines. 2008. PMID: 18767957 Review.

9

Delivery of DNA vaccines: an overview on the use of biodegradable polymeric and magnetic nanoparticles.

Xiang SD, Selomulya C, Ho J, Apostolopoulos V, Plebanski M. Xiang SD, et al. Among authors: plebanski m. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010 May-Jun;2(3):205-18. doi: 10.1002/wnan.88. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2010. PMID: 20391461 Review.

10

Methods to measure T-cell responses.

Plebanski M, Katsara M, Sheng KC, Xiang SD, Apostolopoulos V. Plebanski M, et al. Expert Rev Vaccines. 2010 Jun;9(6):595-600. doi: 10.1586/erv.10.53. Expert Rev Vaccines. 2010. PMID: 20518715 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

234 results

Search Page